HIT (Paris HealthWeek, from 16 to 18 may – Paris, Porte de Versailles)
Download the free guide
Boost your gains
VISIOMED GROUP, Huawei & H2AD are set on their stand
their innovative solutions and connected, adapted to each universe of health :
at home, in a hospital/clinic, long-term care facilities.
Appointment on stand G61.
Paris, may 16, 2017
Connected health is now a reality in daily life. It has nothing to do with a fiction. It is increasingly used by health professionals. VISIOMED GROUP (FR0011067669 ALVMG), Huawei and H2D make an appointment with you to show you in concrete terms how their innovative solutions in telemedicine are implemented, and how they are used the performance and quality of care within health facilities.
VISIOMED GROUP, Huawei and H2AD jointly develop a telemedicine solution that are innovative, adaptable to every need and every context, in the service of the performance of health professionals. The combined strengths of expertise, these offerings are integrated in institution care, at the office, in long-term care Facility, pharmacy or at home.
Their joint stand at the HIT 2017 you will allow it to live an immersion in each of the worlds : at home, in hospital and in long-term care facilities and to visualize how these solutions are revolutionizing the daily lives of health professionals as patients.
At home : a accompaniment of the patient in his environment, with a range of solutions that make up the medical data of the patient to the hospital.
MyHealthBox is a modular offer for the follow-up at home.
Majord’home is the solution to followed home designed for seniors.
Has the hospital or clinic : support for fast and reliable patient’s.
Devices, telemedicine and remote monitoring, which was developed jointly with Huawei and H2AD to support fast and reliable patients.
VisioCheck, the station of telemedicine, which allows measurements in all circumstances.
In long-term care Facility : a care-adapted and custom of residents.
An innovative solution for telemedicine with a cart full-featured mobile designed for teleconsultation and tele-expertise, and the robot, and Pepper.
This show will be the opportunity to better understand the complementarity of the know-how of VISIOMED GROUP, Huawei and H2AD for innovative solutions, remote monitoring, fully adapted to the specificities of each health care facility, such as to the home.
A return to experimentation on these innovative solutions to health connected with different chronic pathologies will also be made during a conference held on Wednesday 17 may 2017, 9 am-11 am (meeting Room Marco Polo – Area Manager of the Salon Hôpital Expo). It will bring together :
Professor Marie-Claire Boiteux (Clermont-Ferrand university hospital), for CardiAuvergne and the follow-up of patients with severe heart failure.
Dr. Magali Giral (CHU of Nantes), for DIVAT and the follow-up of renal transplant recipients.
Dr. Valerie Bourdinaud, Head of the ambulatory long-term care-the Magnolias (Ballainvilliers, Essonne).
About VISIOMED GROUP
Founded in 2007 by Eric Sebban, VISIOMED GROUP is a company specializing in electronic medical new generation. The laboratory develops and markets innovative health products in the promising fields of the self-diagnosis for medical use and well-being. VISIOMED is in particular the inventor of the ThermoFlash®, 1 medical thermometer infrared non-contact.
The products VISIOMED incorporate innovation, technology and design to provide solutions for the prevention and treatment non-drug focused on simplicity, comfort and well-being of its users.
In 2014, VISIOMED GROUP has announced the launch of its range of connected products of health ” BewellConnect® “, thus becoming the 1 laboratory of medical electronics to enter the market with very high potential of the Internet of things (IoT).
Based in Paris, VISIOMED GROUP relies on a team of 105 employees, integrating sales forces dedicated to the commercialization of pharmacy (OTC), among health-care professionals (hospitals, clinics, retirement homes) and, since the end of 2010, in the Large-scale Distribution. In 2015, the Group achieved a turnover of more than 10 Million. VISIOMED GROUP is qualified as “Innovative Company” by Bpifrance.
VISIOMED GROUP is ranked 2nd in the top national on the occasion of the 2014 edition of the Deloitte In Extenso Technology Fast 50, and 2nd in Europe in the sector Health/Biotech/Pharma in the Deloitte Technology Fast 500. In 2016, VISIOMED GROUP has won the ScaleUp Awards organized by KPMG and Growthco and was ranked 1st company in the Healthcare sector in the standings FW500 (FrenchWeb).
More information on www.visiomed-lab.com.
Download the free guide
Boost your gains
